Encompass Health Corporation

Latest Results (20.08.2024):

Revenue Growth

Encompass Health Corporation reported net operating revenue of $1,301.2 million for the second quarter of 2024, reflecting a 9.6% increase compared to $1,187.1 million in the same quarter of 2023. This growth was primarily driven by a 6.7% increase in discharges, including a 4.8% same-store discharge growth, and a 2.0% increase in net patient revenue per discharge.

Income and Earnings

For Q2 2024, Encompass Health Corporation's income from continuing operations attributable to the company per diluted share was $1.13, up 24.2% from $0.91 in Q2 2023. Adjusted earnings per share also saw a significant increase, rising 16.8% to $1.11 from $0.95 in the same period last year.

Cash Flow

Encompass Health Corporation reported cash flows provided by operating activities of $217.4 million for the second quarter of 2024, a 5.2% increase from $206.7 million in Q2 2023. This increase was primarily due to higher net income, partially offset by increased cash tax payments.

Adjusted EBITDA

Adjusted EBITDA for Encompass Health Corporation in Q2 2024 was $271.8 million, representing an 8.9% increase from $249.6 million in the same quarter of the previous year. The growth in Adjusted EBITDA was primarily driven by increased revenue.

Updated Full-Year Guidance

Encompass Health Corporation has updated its full-year 2024 guidance, now expecting net operating revenue between $5,275 million and $5,350 million, up from the previous range of $5,250 million to $5,325 million. Adjusted EBITDA is now projected to be between $1,040 million and $1,075 million, and adjusted earnings per share from continuing operations are expected to be between $3.97 and $4.22.